Nucleusrad
Palo Alto, US · Founded 2022 · 56 employees on LinkedIn · 2 known investors
Find your way into Nucleusrad
Nucleus RadioPharma develops and manufactures radiopharmaceutical products, with production facilities capable of scaling to hundreds of thousands of doses per year. It operates sites including a Minnesota location and Springhouse Innovation Park in Pennsylvania.
Founders & leadership
SM
Stephen M. HahnChief Executive Officer & Board Member
TR
Tyrell RiversNamed on SEC filing
MK
Mary Kate WoldNamed on SEC filing
MR
Michael RossiNamed on SEC filing
NS
Norman SharplessNamed on SEC filing
CM
Chris McDonaldNamed on SEC filing
MN
Manu NairNamed on SEC filing
JB
CC
Charles ConroyNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$72.1M disclosed across 2 rounds · 2022–2023
▶$66.1MraisedApr 2024 · 12 investors · Other Health CareRule 506(b)
▶$66.1MraisedApr 2024 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Tyrell RiversDirector
- Mary Kate WoldDirector
- Michael RossiDirector
- Norman SharplessDirector
- Chris McDonaldDirector
- Manu NairDirector
- Justin ButlerDirector
- Charles ConroyExecutive Officer, Director
- Offering amount
- $66.1M
- Amount sold
- $66.1M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$6MraisedApr 2024 · 3 investors · Other Health CareRule 506(b)
▶$6MraisedApr 2024 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Charles ConroyExecutive Officer, Director
- Justin ButlerDirector
- Manu NairDirector
- Tyrell RiversDirector
- Norman SharplessDirector
- Michael RossiDirector
- Chris McDonaldDirector
- Mary Kate WoldDirector
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Nucleusrad do?
- Nucleus RadioPharma develops and manufactures radiopharmaceutical products, with production facilities capable of scaling to hundreds of thousands of doses per year. It operates sites including a Minnesota location and Springhouse Innovation Park in Pennsylvania.
- Who are Nucleusrad's investors?
- Nucleusrad's investors include Eclipse, OrbiMed.
- How much funding has Nucleusrad raised?
- Nucleusrad has disclosed $72.1M raised across 2 rounds.
- Where is Nucleusrad headquartered?
- Nucleusrad is headquartered in Palo Alto, US.